Orchid Pharma Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|
| Revenue | 188.86 | 243.74 | 227.28 |
| Operating Expense | 158.75 | 203.15 | 190.98 |
| Net Profit | 18.20 | 27.85 | 23.91 |
| Net Profit Margin | 9.64 | 11.43 | 10.52 |
| Earning Per Share | 3.59 | 5.49 | 4.71 |
| EBIDTA | 30.11 | 40.59 | 36.31 |
| Effective Tax Rate | TBA | TBA | TBA |
| Particulars | Jun 2025 |
|---|---|
| Revenue | 188.86 |
| Operating Expense | 158.75 |
| Net Profit | 18.20 |
| Net Profit Margin | 9.64 |
| Earning Per Share | 3.59 |
| EBIDTA | 30.11 |
| Effective Tax Rate | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 819.37 | 665.90 | 556.97 |
| Operating Expenses Annual | 708.69 | 582.28 | 499.72 |
| Operating Profit Annual | 141.07 | 141.20 | 114.23 |
| Interest Annual | 16.33 | 32.23 | 32.01 |
| Depreciation | 31.75 | 54.74 | 86.99 |
| Net Profit Annual | 94.75 | 55.25 | -52.77 |
| Tax Annual | -3.23 | TBA | TBA |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 819.37 |
| Operating Expenses Annual | 708.69 |
| Operating Profit Annual | 141.07 |
| Interest Annual | 16.33 |
| Depreciation | 31.75 |
| Net Profit Annual | 94.75 |
| Tax Annual | -3.23 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 18.31 | 0.45 | 14.75 |
| Cash Flow from Operations | 130.73 | 13.39 | 89.57 |
| Cash Flow from Investing | -315.81 | -26.70 | 112.93 |
| Cash Flow from Financing | 167.07 | 31.17 | -216.80 |
| Cash Flow at the End | 0.29 | 18.31 | 0.45 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 18.31 |
| Cash Flow from Operations | 130.73 |
| Cash Flow from Investing | -315.81 |
| Cash Flow from Financing | 167.07 |
| Cash Flow at the End | 0.29 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 17.26 | 15.46 | 12.06 |
| PBIT Margin (%) | 13.21 | 7.23 | -3.56 |
| PBT Margin (%) | 12.42 | 7.01 | -3.45 |
| Net PROFIT Margin (%) | 11.56 | 8.14 | -0.86 |
| Return On Networth / Equity (%) | 3.15 | 0.81 | TBA |
| Return On Networth /Employed (%) | 3.33 | 2.34 | TBA |
| Return On Assets (%) | 7.75 | 5.37 | -0.46 |
| Total Debt / Equity (X) | 0.24 | 0.43 | 0.53 |
| Asset Turnover Ratio (%) | 0.67 | 0.66 | 0.53 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 17.26 |
| PBIT Margin (%) | 13.21 |
| PBT Margin (%) | 12.42 |
| Net PROFIT Margin (%) | 11.56 |
| Return On Networth / Equity (%) | 3.15 |
| Return On Networth /Employed (%) | 3.33 |
| Return On Assets (%) | 7.75 |
| Total Debt / Equity (X) | 0.24 |
| Asset Turnover Ratio (%) | 0.67 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 630.71 | 573.06 | 583.65 |
| Total Current Assets Annual | 782.29 | 493.79 | 383.07 |
| Non Current Assets Annual | 769.91 | 729.46 | 711.12 |
| Total Shareholders Funds Annual | 1,218.32 | 731.96 | 677.95 |
| Total Assets Annual | 1,552.20 | 1,223.26 | 1,094.19 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 630.71 |
| Total Current Assets Annual | 782.29 |
| Non Current Assets Annual | 769.91 |
| Total Shareholders Funds Annual | 1,218.32 |
| Total Assets Annual | 1,552.20 |
EPS (INR)
Expected
2.94
Reported
2.94
Surprise
0.00%
Mar 2025
EPS beaten by 0.00%
Dec 2024
EPS beaten by 0.23%
Sep 2024
EPS beaten by 0.00%
